Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Amgen initiates phase I trials with KGF

April 26, 1996

Byk Gulden claims agents for H. pylori control

April 26, 1996

YM-47813 revealed at 211th ACS

April 19, 1996

Taisho reports 5-HT4 agonists for GI disorders

April 19, 1996

FDA approves Prilosec + Biaxin combination for H. pylori

April 19, 1996

Byk Gulden researches anti-Helicobacter agents

April 19, 1996

Vaqta gets the green light from FDA

April 12, 1996

Nisin in testing for Helicobacter infections

April 12, 1996

Improved Havrix approved by FDA

April 12, 1996

OraVax granted patent on H. pylori vaccine technology

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.